 High-dose itraconazole treatment severe mycoses patients systemic mycoses prior treatment failures itraconazole mg/day mean duration months patients AIDS improvement stabilization fungal infections high-dose itraconazole patients treatment failures relapse progression doses Treatment failures patients AIDS cryptococcal meningitis failures low serum itraconazole concentrations micrograms/ml patients patients trough levels serum micrograms/ml patient mg/day progressive infection reduction dose mg/day Side effects reversible adrenal insufficiency patient severe hypokalemia mild diastolic hypertension rhabdomyolysis patient hypokalemia hypertension patients tenderness patient mean decrease serum potassium treatment significant patients severe systemic mycoses prolonged high-dose itraconazole treatment mg/day upper limits acceptable long-term treatment